[EN] TRICYCLIC COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS<br/>[FR] COMPOSÉS TRICYCLIQUES ET COMPOSITIONS UTILISÉS COMME INHIBITEURS DE KINASES
申请人:NOVARTIS AG
公开号:WO2017103824A1
公开(公告)日:2017-06-22
The present invention provides compounds of Formula (A): (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent, and methods of using the compositions and combinations to treat conditions including cancers.
本发明提供了如下式(A)的化合物:(I)以及所述化合物的盐,以及这些化合物用于治疗与Raf激酶活性相关的疾病的治疗用途。本发明进一步提供了包含这些化合物的药物组合物,以及包含这些化合物和治疗协同剂的组合物,以及使用这些组合物和组合物来治疗包括癌症在内的病症的方法。